baber/WOPTO huggingface dataset:
Patent AU-604207-B2 (AU)
Title: Device for separating the components of a liquid sample having higher and lower specific gravities
Inventor: BURNS JAMES A
IPC: B01L3/14
Filed: 1988-10-05
Granted: 1990-12-06
Abstract: A device is provided for separating the components of a liquid sample by centrifugation by dividing that portion of the sample having a higher specific gravity from that portion having a lower specific gravity, by utilizing a dual component assembly arranged to move in an evacuated container into the area adjacent the two portions of the sample under centrifugal force. The assembly includes a substantially rigid core component which nests within a cup-shaped elastomeric component, and which components interact with each other to provide alternating dual seals and open flow paths in response to different pressure differentials on each side thereof.
Patent AU-696735-B2 (AU)
Title: Packet transmission system
Inventor: SHIGA TOMOHISA
IPC: H04L12/64
Filed: 1995-07-20
Granted: 1998-09-17
Abstract: A data receiving device comprising receiving means for receiving a cycle timer packet, an isochronous-type packet and an asynchronous-type packet from an external device, isochronous-type packets being transmitted after said cycle timer packet and before asynchronous-type packets, said asynchronous-type packets being transmitted in a period from the end of transmission of said isochronous-type packets until a next cycle timer packet is transmitted, a cycle timer for outputting time information, means for extracting revising information for revising said cycle timer from said received cycle timer packet, means for revising said time information of said cycle timer according to said extracted revising information, storage means for temporarily storing said isochronous-type packet, means for extracting time information added to said isochronous-type packet, means for comparing said extracted time information with time information of said cycle timer and means for retrieving said isochronous-type packet from said storage means when said extracted time information corresponds to time information of said cycle timer.
Patent AU-623361-B2 (AU)
Title: Selective removal of immune complexes
Inventor: HUSTON JAMES S
IPC: A61K35/14
Filed: 1988-10-17
Granted: 1992-05-14
Abstract: Disclosed is a method and a family of materials useful for removing immune complexes from blood preferentially to soluble antibodies. The material comprises analogs of proteins which bind to the Fc region of immunoglobulin. The analogs are produced by truncating or otherwise altering the amino acid sequence of the binding protein to reduce their affinity for Fc. An array of such analogs disposed about the surface of an insoluble matrix has the ability to form multiple points of attachment to the multiple Fc's in a complex so as to bind complex strongly, whereas only weak associations are developed between the Fc region of soluble IgG and individual analogs. The preferred analogs are truncated proteins homologous to a portion of the domains of Protein A or Protein G which bind with Fc. Complex may be removed from whole blood or serum using the material and conventional plasmapheresis techniques.
Patent AU-747063-B2 (AU)
Title: Utilization of CD137 in order to promote the proliferation of peripheral monocytes
Inventor: SCHWARZ HERBERT
IPC: A61K38/17
Filed: 1999-03-05
Granted: 2002-05-09
Abstract: The invention relates to the utilization of monocytes growth factor CD137 or of a functional analogue thereof in order to produce a medicament for promoting the proliferation of peripheral monocytes of a mammal. The invention especially relates to the utilization of the growth factor for treating pathological conditions.
Patent AU-743489-B2 (AU)
Title: 1,3,4-thiadiazoles useful for the treatment of CMV infections
Inventor: TURNER STEVEN R
IPC: C07D417/12
Filed: 1999-03-16
Granted: 2002-01-24
Abstract: The present invention presents novel 1,3,4-thiadiazole derivatives of formula I which have useful antiviral activity against herpes virus, cytomegalovirus (CMV).
Patent AU-615542-B2 (AU)
Title: Delayed cache write enable circuit for a dual bus microcomputer system with an 80386 and 82385
Inventor: BEGUN RALPH MURRAY
IPC: G06F12/08
Filed: 1989-05-05
Granted: 1991-10-03
Abstract: In a dual bus microcomputer system using a cache memory and a cache controller, the timing requirements placed on non-cache memory components by the cache controller are more stringent than the timing requirements placed on the non-cache memory components by the microprocessor. A logic circuit operates on the cache write enable (CWE) signals, and delays those signals in the event of a cache read miss. Delaying the CWE signals relaxes the timing requirements placed on non-cache memory components and at the same time does not impact wait state parameters for read miss operations.
Patent AU-565354-B2 (AU)
Title: Bioadhesive compositions and methods of treatment therewith
Inventor: ROBINSON J R
IPC: A61K9/22
Filed: 1984-11-09
Granted: 1987-09-10
Abstract: A controlled release treatment composition. The composition includes a bioadhesive and an effective amount of a treating agent. The bioadhesive is a water-swellable, but water-insoluble, fibrous cross-linked carboxy-functional polymer containing a plurality of repeating units of which at least about 80 weight percent contain at least one carboxyl functionality.
Patent AU-775989-B2 (AU)
Title: Adhesive composition and method for producing it
Inventor: NAKATSUKA KAZUMITSU
IPC: A61K6/884
Filed: 2000-05-26
Granted: 2004-08-19
Abstract: Provided are a substantially transparent adhesive composition for hard tissue, and a method for producing it. The adhesive composition exhibits good adhesiveness to hard tissue, especially to both enamel and dentin, and has the advantage of improved bonding durability especially in water. This contains (a) a water-insoluble, acid group-containing polymerizable monomer which has, in the molecule, at least one hydrocarbon group selected from an alkylene group having from 8 to 25 carbon atoms an alkyl group having from 8 to 25 carbon atoms and an aromatic group, and/or its salt, and (b) water, and has pH of from 1.0 to 6.0. This is produced by mixing (a) a water-insoluble, acid group-containing polymerizable monomer which has, in the molecule, at least one hydrocarbon group selected from an alkylene group having from 8 to 25 carbon atoms an alkyl group having from 8 to 25 carbon atoms and an aromatic group, (b) a basic compound capable of forming a soluble salt with the acid group-containing polymerizable monomer, and (c) water to thereby give a mixture having pH of from 1.0 to 6.0.
Patent AU-695045-B2 (AU)
Title: Heteroaromatic oxazole compounds and use thereof
Inventor: HARUTA JUNICHI
IPC: C07D207/333
Filed: 1995-12-18
Granted: 1998-08-06
Abstract: A heterocyclic aromatic oxazole compound of the formula (I) <CHEM> wherein Z is an oxygen atom; one of R and R1 is a group of the formula <CHEM> wherein R3 is lower alkyl, amino or lower alkylamino, and R4, R5, R6 and R7 are the same or different and each is hydrogen atom, halogen atom, lower alkyl, lower alkoxy, trifluoromethyl, hydroxy or amino, provided that at least one of R4, R5, R6 and R7 is not hydrogen atom, and the other is an optionally substituted cycloalkyl, an optionally substituted heterocyclic group or an optionally substituted aryl; and R2 is a lower alkyl or a halogenated lower alkyl, and a pharmaceutically acceptable salt thereof. The heterocyclic aromatic oxazole compound and pharmaceutically acceptable salts thereof have antipyretic action, analgesic action, anti-inflammatory action, and particularly, selective inhibitory action on cyclooxygenase-2 (COX-2), and are expected to be useful as anti-inflammatory agents with less side-effects such as digestive tract disorders.
Patent AU-580058-B2 (AU)
Title: Tool for rotative metal cutting
Inventor: SCHNEIDER RUDOLF
IPC: B23B29/034
Filed: 1985-05-10
Granted: 1988-12-22
Abstract: The invention refers to a tool assembly for cuttingly machining of an at least partially closed inner surface of a workpiece, e.g. a bore. It comprises an essentially rod-shaped tool support having a machining tool mounted on its end and which is adapted to be inserted into the cavity to be machined. The tool support comprises a rod member with a continuous opening extending in axial direction and with parallel supporting surfaces arranged in the region of the both ends and extending with an angle to the longitudinal axis of the rod member. A machining tool supporting member having a machining tool mounted at one end is slidably mounted at one end of the rod member and rests against the first supporting surfaces of the rod member. A control member is slidably mounted at the other end of the rod member perpendicularly to the axis of the tool support and resting on the second supporting surface, serving for the pushing-out and retiring of the tool supporting member. To this purpose a connecting member extending through the opening of the rod member is provided, being connected, with its one end, to the machining supporting member and, with its other end, to the control member, thereby coupling these elements together in a predetermined distance.
Patent AU-760074-B2 (AU)
Title: Grain cleaner
Inventor: MANNING DONALD R
IPC: B07B13/02
Filed: 1999-06-16
Granted: 2003-05-08
Abstract: A grain cleaner is taught including features for facilitating maintenance and repair of the cleaner over previous grain cleaners. In particular, the grain cleaner has an indent cylinder assembly (40,78) which includes a removable cylinder (40,78). The cylinder (40,78) is removed by unwrapping it from the frame (70). The grain cleaner also includes at least some augers (34c) with drop away troughs (34b). The grain cleaner also includes grain cleaning assemblies such as, for example, indent cylinders (40,78) and rotary screen drums (25) and/or grain cleaning assemblies drive systems which are mounted on framework members (124,126) capable of pivoting outwardly from the machine allowing access to machinery and components positioned centrally within the grain cleaner. <IMAGE>
Patent AU-573006-B2 (AU)
Title: Sustained release medicament in polymer coated enteric composition
Inventor: HARRISON PAUL JOHN
IPC: A61K9/54
Filed: 1985-06-03
Granted: 1988-05-26
Abstract: A pharmaceutical composition of a medicament, such as a 5-(pyridinyl)-2(IH) pyridone, in sustained release unit dosage form for oral administration. The composition is in the form of beads within a capsule of gelatin or the like. Each bead comprises an inert particulate core having adhered thereto a coating of particles of the medicament. This coating is in turn surrounded by a sustaining coating of three different polymers with different solubility profiles to allow a sustained release of the medicament both in the low pH environment of the stomach and at a higher pH values prevailing in the intestine.
Patent AU-578297-B2 (AU)
Title: Chemical refill system
Inventor: LIPISKO BRUCE A
IPC: C30B31/16
Filed: 1985-06-21
Granted: 1988-10-20
Abstract: A system for automatically filling a bubbler (170), or other vapor delivery system from a reservoir (102), in which the conduit system (132, 150, 152, 154, 156) is purged and pressurized with inert gas, using a unique refill reservoir (102), level sensing (103, 176) and valving system (140, 160, 190, 192).
Patent AU-661208-B2 (AU)
Title: A bag for curing food
Inventor: TIRKKONEN TAPANI
IPC: B65D81/28
Filed: 1993-10-14
Granted: 1995-07-13
Abstract: The present invention concerns a bag for curing food which will he placed into the bag, said bag being made from a heat-resistant, foldable material, preferably from metal foil or paper or similar material coated with a metal film. Conventionally, simultaneous flavoring and curing of food is awkward. The interior of the bag (1) according to the invention contains material releasing flavoring gas, whereby desired flavoring of food curing inside the bag is attained. <IMAGE>
Patent AU-638235-B2 (AU)
Title: Contrast media
IPC: A61K49/04
Filed: 1990-03-09
Granted: 1993-06-24
Abstract: The invention relates to improved contrast media containing non-ionic contrast agents, e.g. non-ionic iodinated X-ray contrast agents, the improvement being achieved by incorporation of sodium at 20-60 mM/l.
Patent AU-746192-B2 (AU)
Title: Compounding assembly for nutritional fluids
Inventor: DIGIANFILIPPO ALEANDRO
IPC: A61M5/142
Filed: 1999-08-12
Granted: 2002-04-18
Abstract: A mixing assembly which transfers a number of nutritional fluids from individual source containers into a collection container while noninvasively sensing the type of fluid being transferred is provided. The mixing assembly utilizes a transfer set to establish fluid communication between the source containers and the collection container. A sensing assembly is configured to noninvasively sense a number of the types of fluid flowing through the transfer set to help to prevent improper mixing. For other fluids for which the sensing assembly alone may not be able to distinguish with the desired accuracy, the mixing device utilizes a method to approximate the flow rate of that fluid with the flow rate also providing an indication of that type of fluid. By combining the output of the sensing assembly with the flow rate determination, additional fluids can be identified.The assembly includes a controller that executes a number of routines that minimize the occurrence of false alarms, while insuring accurate and reliable compounding of prescriptions.
Patent AU-584691-B2 (AU)
Title: Production of pasta
Inventor: YANN HSU JAU
IPC: A23L7/109
Filed: 1986-04-15
Granted: 1989-06-01
Abstract: A process for the production of pasta characterised in that flour is mixed with from 15% to 33% by weight of water based on the weight of flour and water to form a dough, the dough is extruded through a pasta die (10) provided with at least three superimposed nozzles (11) for forming dough sheets, (12) and the extruded, superimposed dough sheets (12) are compressed into one dough sheet (15) which is then cut to form the desired pasta shape.
Patent AU-698360-B2 (AU)
Title: Three-phase pharmaceutical form with constant and controlled release of amorphous active ingredient for single daily application
Inventor: KERC JANEZ
IPC: A61K9/28
Filed: 1996-05-17
Granted: 1998-10-29
Abstract: PCT No. PCT/SI96/00012 Sec. 371 Date Nov. 12, 1997 Sec. 102(e) Date Nov. 12, 1997 PCT Filed May 17, 1996 PCT Pub. No. WO96/36318 PCT Pub. Date Nov. 21, 1996Described is a novel three-phase pharmaceutical form with constant and controlled release of an amorphous active ingredient stabilized with polymers for a single daily peroral application, which is especially suitable for active ingredients existing in amorphous form or in one or more polymorphous forms, which exhibit poor solubility in crystal form depending on the polymorphous form, particle size and the specific surface area of the active ingredient. The active ingredient can be used in its amorphous or any polymorphous form, which in the process of the preparation of the three-phase pharmaceutical form according to the invention is converted into the amorphous form. The three-phase pharmaceutical form with constant and controlled release of an amorphous active ingredient for a single daily peroral application contains a core consisting of a first and a second phase and a coating representing the third phase. In the first phase the three-phase pharmaceutical form contains an amorphous active ingredient, the water-soluble polymer polyvinylpyrrolidone and a cellulose ether as carriers of the amorphous active ingredient and simultaneously as inhibitors of its crystallization, a surfactant that improves the solubility of the active ingredient and promotes the absorption of the amorphous active ingredient from gastrointestinal tract, in the second phase it contains a cellulose ether and a mixture of mono-, di- and triglycerides as sustained release agents and the third phase is represented by a poorly soluble or gastro-resistant film coating, which in the first few hours after the application controls the release of the active ingredient and can consist of an ester of hydroxypropylmethylcellulose with phthalic anhydride or of a copolymerizate based on methacrylic acid and ethyl acrylate. Described is also a process for the preparation of this pharmaceutical form.
Patent AU-760496-B2 (AU)
Title: Connector system for fibre optic male contacts
Inventor: DIXON TREVOR JAMES
IPC: G02B6/38
Filed: 1999-09-01
Granted: 2003-05-15
Abstract: The connector system comprises a standard DIN 41612 two-part connector for printed circuit boards having a plug shell (1) inserted into a socket shell (2), which shells have grids (5, 12) and opposed cavities (6, 13) for separate contacts. A front plug shell hollow insert (16) and a rear plug shell hollow insert (17) are assembled in communication to one another in a cavity (6) of the plug shelf (1). A front socket shell hollow insert (31) and a rear socket shell hollow insert (32) are assembled in communication to one another in a cavity (13) of the socket shell (2) opposed to the cavity (6) of the plug shell (1). An alignment sleeve (48) is placed in a floating condition in a housing (49) formed in the front plug shell insert (16). Alignment sleeve (48) allows front to front aligned housing of the ferrules (52) of two fibre optic male contacts plugged into the rear plug shell insert (17) and rear socket shell insert (32). <IMAGE>
Patent AU-700091-B2 (AU)
Title: Method of making (S)-3-(aminomethyl)-5-methylhexanoic acid
Inventor: GROTE TODD MICHEL
IPC: C07C227/42
Filed: 1996-05-13
Granted: 1998-12-24
Abstract: A method of making (+/-)-3-(aminomethyl)-5-methylhexanoic acid that comprises condensing isovaleraldehyde with to form primarily reacting the with a cyanide source to form decarboxylating the to form hydrolyzing the with an alkali or alkaline earth metal hydroxide to form an alkali or alkaline earth metal carboxylate salt; and hydrogenating the alkali or alkaline earth metal carboxylate salt to form (+/-)-3-(aminomethyl)-5-methylhexanoic acid, wherein R1 and R2 are the same or different and are hydrogen, C1-C6 alkyl, aryl, benzyl, or C3-C6 cycloalkyl. The present invention also provides a method of making (+/-)-3-(aminomethyl)-5-methylhexanoic acid that comprises condensing isovaleraldehyde with to form primarily reacting the with a cyanide source to form decarboxylating the to form an alkali or alkaline earth metal carboxylate salt; and hydrogenating the alkali or alkaline earth metal carboxylate salt to form (+/-)-3-(aminomethyl)-5-methylhexanoic acid.
Patent AU-683638-B2 (AU)
Title: Oil barrier
Inventor: SCHIWEK HELMUT
IPC: E02B15/04
Filed: 1994-01-08
Granted: 1997-11-20
Abstract: PCT No. PCT/DE94/00008 Sec. 371 Date Jul. 24, 1995 Sec. 102(e) Date Jul. 24, 1995 PCT Filed Jan. 8, 1994 PCT Pub. No. WO94/17249 PCT Pub. Date Aug. 4, 1994In order to control oil accidents and to prevent the oil film drifting on the water from spreading, an oil adsorber 1 is provided, in particular shaped as a barrier 2. This barrier 2 is designed in two parts. Both cells 9, 10 are completely filled with glass fiber material or with corresponding fiber mats 11, 12. The glass fibers 28, 30 of the top cell 9 are waterproofed, by an appropriate coating, whereas the fibers of the bottom cell 10 are not treated, so that they absorb water 6. In both cases epoxy resin or a synthetic resin having the same or similar properties are used, so that a long service life is achieved with optimum solidity and design possibilities. The oil adsorbers 1 thus obtained may be used both as barriers 2 and as flat suction elements, for example to clear bilge waters from ships 3. It is also conceivable to use the flat or funnel-shaped elements for collecting components of an aqueous solution, for example.
Patent AU-767609-B2 (AU)
Title: Charging control in a mobile telecommunications system
Inventor: NILSSON PATRIK
IPC: H04W8/20
Filed: 2000-06-13
Granted: 2003-11-20
Abstract: A method of controlling charging for a subscriber of a home network when the subscriber is roaming in a foreign network, Subscribers are registered with the foreign network with the registration process involving the transfer, from the home network to the foreign network, of one or more charging events predefined for the subscriber. In the event that a charging event occurs for the subscriber a corresponding notification message is sent from the foreign network to the home network. Thereafter, the home network is able to terminate the subscriber's registration with the foreign network and/or restrict the subscriber's access to network services.
Patent AU-721773-B2 (AU)
Title: FGF9 as a specific ligand for FGFR3
Inventor: YAYON AVNER
IPC: A61K39/00
Filed: 1996-06-12
Granted: 2000-07-13
Abstract: The present invention concerns fibroblast growth factor receptor 3 (FGFR3) as a novel marker for mesenchymal skeletal progenitor cells. By utilizing this novel marker it was possible both to identify and locate mesenchymal skeletal progenitor cells in a tissue, as well as to obtain a substantially pure culture of such cells. The pure culture of the mesenchymal skeletal progenitor cells may be used, optionally after various manipulations ex vivo, as an active ingredient in pharmaceutical compositions or implants for the purpose of bone and/or cartilage repair. FGFR3 may also be used as a marker for the identification and the localization of cartilage- and bone-derived tumors. Agents capable of binding to FGFR3 may also be used for targeting cytotoxic agents to cartillage- and bone-derived tumors.The present invention concerns fibroblast growth factor receptor 3 (FGFR3) as a novel marker for mesenchymal skeletal progenitor cells. By utilizing this novel marker it was possible both to identify and locate mesenchymal skeletal progenitor cells in a tissue, as well as to obtain a substantially pure culture of such cells. The pure culture of the mesenchymal skeletal progenitor cells may be used, optionally after various manipulations ex vivo, as an active ingredient in pharmaceutical compositions or implants for the purpose of bone and/or cartilage repair. FGFR3 may also be used as a marker for the identification and the localization of cartilage- and bone-derived tumors. Agents capable of binding to FGFR3 may also be used for targeting cytotoxic agents to cartillage- and bone-derived tumors.
Patent AU-636375-B2 (AU)
Title: Heteroaryl-3-oxo-propanenitrile derivatives useful in stimulating myelopoiesis
IPC: C07D491/048
Filed: 1990-07-11
Granted: 1993-04-29
Abstract: PCT No. PCT/EP90/01129 Sec. 371 Date Mar. 12, 1991 Sec. 102(e) Date Mar. 12, 1991 PCT Filed Jul. 11, 1990 PCT Pub. No. WO91/01309 PCT Pub. Date Feb. 7, 1991.Heteroaryl-3-oxo-propanenitrile derivatives of formula (I)   <IMAGE> (I)  wherein X represents an oxygen atom or a -CH(R4)-, -O-CH(R4)-,-S(O)n-, -S(O)n-CH(R4)-, -CH(R4)-O-, -CH(R4)-S(O)n- or -CH(R4)-CH2- group wherein n is 0, 1 or 2; R1 represents C1-C6 alkyl, pyridyl or unsubstituted or substituted phenyl; R2, R3 and R4 are as herein defined; and Q is hydrogen, carboxy, C2-C7- alkoxycarbonyl or a -CON(Ra)Rb group, Ra and Rb being as defined herein; and their pharmaceutically acceptable salts are useful in stimulating myelopoiesis in bone marrow suppressed mammals.
Patent AU-587270-B2 (AU)
Title: Process and apparatus for regulating the synchronization of a pair of rolls
Inventor: SCHMITZ FERNAND
IPC: B21B1/16
Filed: 1986-08-14
Granted: 1989-08-10
Abstract: Two rolls are supported laterally in bearings in two pairs of side-by-side members with the members being supported by a frame. Adjustment of synchronization and registration is accomplished by adjusting the relative positions of the side-by-side members in or against the rolling direction. The relative positions of the rolls can be adjusted by use of notches engraved in the ends of the rolls; and can be continuously monitored with the aid of a stroboscope light. Magnetic signal devices and other sensors are also suitable for monitoring. Continuous adjustment of roll position is accomplished through low-pitch screws or through hydraulic or electric positioning motors.